Theme: Research and Methodology Implemented on Influenza Vaccines & Respiratory diseases

IRDI Vaccines 2016

IRDI Vaccines 2016

Welcome Message

Giulio Tarro

Prof. Giulio Tarro

Chairman Committee of Biotechnologies and Virus Sphere Foundation de Beaumont Bonelli for Cancer Research, Italy

Greetings,

The acuteness of the influenza problem and fundamental importance ofresearch aimed at uncovering its viruses places the theme of virai involvement in vaccines among the most interesting and urgent problems in the field of medicai science today.

It is therefore an honor for me and a great privilege to speak about the commitment of the OMICS Group in sponsoring the International Congress IRDI entitled "Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics", Furthermore, the OMICS Group wishes to extend this commitment into the future: it is their intention to continue these conferences in the next years. The topics to be selected shall cover a wide range and encompass the most up-to-date information on the multifactorial events which lead to influenza pandemics in the world.

I would like to express my sincere thanks to the members of the Organizing Committee and to ali who have contributed with their participation, help and interest in the success of this conference.

The knowledge we have gained today concerning this virus and its involvement in human infectious diseases represents one of the most important breakthroughs in the advancement of human influenza vaccine research

Sincerely,





About Conference

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

PeerPoint Medical Education Institute designates the live format for this educational activity for AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Conference Series LLC is conducting its “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics “during December 01-02, 2016 at Atlanta, USA. The conference highlights the theme Research and Methodology Implemented on Influenza Vaccines & Respiratory diseases. IRDI Vaccines 2016 takes an initiative to provide health practitioners an understanding about the vital role of IRDI vaccines 2016 in health and healing. The conference also includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Influenza is a major respiratory pathogen causing annual outbreaks and occasional pandemics. Influenza vaccination is the major method of prophylaxis. Currently annual influenza vaccination is recommended for groups at high risk of complications from influenza infection such as pregnant women, young children, people with underlying disease and the elderly, along with occupational groups such as healthcare workers and farm workers. There are two main types of vaccines available: the parenteral inactivated influenza vaccine and the intranasal live attenuated influenza vaccine. Influenza continues to remain among the most important respiratory infections causing annual seasonal epidemics and the occasional pandemic. The 2009 H1N1 flu virus (referred to as “swine flu “early on) is a new influenza virus strain that is causing illness in people. This new virus strain was first detected in people in the US in April 2009 and is spreading from person-to-person worldwide, probably in much the same way that regular seasonal influenza viruses spread. On June 11, 2009, the World Health Organization (WHO) declared that a pandemic of 2009 H1N1 flu was underway. On September 15, 2009, FDA approved four Influenza A (H1N1) 2009 Monovalent Vaccines for the active immunization of individuals against influenza disease caused by pandemic (H1N1) 2009 virus.

Why to Attend??

IRDI Vaccines 2016 takes an initiative to provide health practitioners an understanding about the vital role of IRDI vaccines in health and healing. IRDI Vaccines 2016 is aimed to provide a distinguished opportunity to the professionals in the field of virology and vaccines to discuss latest research and challenges in the field. IRDI Vaccines 2016 is designed to provide an exclusive platform for Virologist, Scientists, and other health-care professionals, researchers and students working in the field to deliberately, exchange views and their experiences in front of a large international audience. IRDI Vaccines 2016 welcomes Presidents, CEO’s, Scientists and Researchers in Viruses and Vaccines sectors, Delegates and industrial executives from pharmaceuticals and healthcare industries to participate in the interactive scientific-sessions, B2B meetings and panel discussions. The companies dealing with IRDI vaccines medication and supplements can exhibit their products in the IRDI Vaccines 2016 exhibition and expo.

Target Audience:

  • Vaccinologists
  • Immunologists
  • Virologists
  • Health-Care Professionals
  • Researchers and Scientists
  • Training Institutes
  • Universities and Colleges Students
  • Associations and Societies
  • Pharmaceutical and Healthcare Companies
  • Business Entrepreneurs
  • This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. –

See more at: http://h1n1-influenza.conferenceseries.com/

 





Tracks/Sessions

13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics

Conference Series LLC Conferences invites all the participants from all over the world to attend “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics” which will be held during December 01-02, 2016 at Atlanta, USA which includes Prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions. The Theme of the conference is "Research and Methodology Implemented on Influenza Vaccines & Respiratory diseases".

IRDI Vaccines 2016 hosting presentations from Global Leaders in the field across the Globe and bringing together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. There will be opportunities for those selected to present at the meeting to also publish a manuscripts and abstracts from their talk in the Journal of IRDI Vaccines or its sister publication Immunome ResearchConference Series LLC organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as Editorial board members.

Track 1: Status of vaccines research and methodology

The word “vaccine” originates from the Latin Variolae vaccine (cowpox), which Edward Jenner demonstrated in 1798 could prevent smallpox in humans.  Today the term ‘vaccine’ applies to all biological preparations,  produced from living organisms,  that enhance immunity against disease and either prevent (prophylactic vaccines) or,  in some cases,  treat disease (therapeutic vaccines).  Vaccines research and development are administered in liquid form, either by injection, by oral,  or by intranasal routes. Vaccination is the administration of antigenic material (a vaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen.  Vaccination is the administration of antigenic material to stimulate an individual's immune system to develop adaptive immunotherapeutic to pathogen.  A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. 

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

 

Related Conferences:

Vaccines Conferences  June 16-18, 2016 Rome, Italy; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA; Cancer Vaccines-Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Vaccines Conferences  June 16-18, 2016 Rome, Italy; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, Dubai, UAE; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Melbourne, Australia; Vaccines for Children & Vaccine Preventable Disease Conference South Iselin, NJ; Infectious Diseases in Children A Primary Care and Hospitalist Approach Florida, USA; Colorado Regional Immunization Summit 2015 Grand Junction, CO; 20th Annual Massachusetts Immunization Action (MIAP) Paediatric Immunization Skills Building Conference Marlborough, Massachusetts; GAVI Pledging Conference 2015 Berlin, Germany; Vaccine Summition

Track 2:  Influenza virus - Immunology  and Genetic Features

Immunology is the branch of biomedical sciences concerned with all aspects of the immunological research in all multicellular organisms.  Antiviral resistance in influenza may not only develop during treatment but also sometimes transmit widely to replace susceptible strains in the absence of drug pressure.  Although instances of antiviral drug resistance among influenza viruses have occurred during antiviral therapy, resistant influenza strains have spread widely in the absence of such drug pressure.  Influenza occurs in outbreaks and epidemics worldwide, mainly during the winter season. Although acutely debilitating, influenza is usually a self-limited infection; however, it is associated with increased morbidity and mortality in certain high-risk populations. 

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related conferences:

International Conference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Australia; 12th Euro Global Summit on Cancer Therapy, Sept 26-28, 2016, UK; International Conference and Exhibition on Pediatric Oncology, Aug 4-6, 2016, Canada; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccines Conferences  June 16-18, 2016 Rome, Italy; Cancer Vaccines: Targeting Cancer Genes for Immunotherapy (X1) British Columbia, Canada; Cancer Immunotherapy: Immunity and Immunosuppression Meet Targeted Therapies (J6) British Columbia, Canada; Immunotherapy and Vaccine Summit Boston, USA; Cancer Vaccines-Advancing Immuno-Oncology London, UK;9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; The Foetus New born USA; Vaccine World CIS CEE, Russian Federation;  Keystone Symposia Advancing Vaccines in the Genomics Era (T1) Rio de Janeiro, Brazil; Chikungunya Lille, France; Venoms Conference, UK;  Vaccines World China Chengdu, China;  Child Hood Infections Chengdu, China; 22nd Annual Biologics World Taiwan Taipei, Taiwan; 2nd Antivirals Congress Massachusetts, United States; Vaccinology conference Sydney Australia; Vaccines R&D-2015 A New Era in Vaccine Discovery Baltimore, USA; Moldova Vaccine Summit, UK; Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Vaccines Conferences  June 16-18, 2016 Rome, Italy; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, Dubai, UAE; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Melbourne, Australia; Vaccines for Children & Vaccine Preventable Disease Conference South Iselin, NJ; Infectious Diseases in Children A Primary Care and Hospitalist Approach Florida, USA; Colorado Regional Immunization Summit 2015 Grand Junction, CO

Track 3: Transmission and Diagnosis of H1N1 Influenza Virus

H1N1 flu is also known as swine flu.  It's called swine flu because in the past, the people who caught it had direct contact with pigs.  That changed several years ago, when a new virus emerged that spread among people who hadn't been near pigs.  In 2009, H1N1 was spreading fast around the world, so the World Health Organization called it a pandemic. Since then, people have continued to get sick from swine flu, but not as many.  H1n1 diagnosis is recommended on suspect cases of novel influenza A H1N1 (swine flu).  Active infection with swine flu diagnosis influenza can only be confirmed by polymerase chain reaction (PCR) assays, including sub-typing and further characterization by other special PCR assays. 

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related Conferences:

Vaccines Conferences  June 16-18, 2016 Rome, Italy; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11thGlobal Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; RSV vaccines for the World, USA; Influenza Vaccines for the World, Portugal; Pathogenesis of Respiratory Viruses, USA; Influenza Vaccines, Bangkok, Thailand; 3rd Cancer Vaccines and Gene Therapy (CVGT) Meeting The Desmond in Malvern, USA; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA; 6th Immunotherapeutics  Immuno monitoring Conference California, USA; The Foetus New born USA; Vaccine World CIS CEE, Russian Federation Cell Biology and Immunology of Persistent Infection (A8), Alberta, Canada January 31—February 4, 2016. Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Vaccines Conferences  June 16-18, 2016 Rome, Italy; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, Dubai, UAE; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Melbourne, Australia; Vaccines for Children & Vaccine Preventable Disease Conference South Iselin, NJ; Infectious Diseases in Children A Primary Care and Hospitalist Approach Florida, USA; Colorado Regional Immunization Summit 2015 Grand Junction.

Track 4: Influenza Epidemiology and Disease Management

Influenza occurs in distinct outbreaks of varying extent every year.  The influenza epidemiology pattern reflects the changing nature of the antigenic properties of influenza viruses, and their subsequent spread depends upon multiple factors, including transmissibility of the virus and the susceptibility of the population.  Influenza A viruses, in particular, have a remarkable ability to undergo periodic changes in the antigenic characteristics of their envelope glycoproteins, the hemagglutinin and the neuraminidase.  Influenza is a highly infectious disease which can occur as a pandemic, epidemic, outbreak and in form of sporadic cases.  While in home isolation, patients and other household members should be given infection control instructions, including frequent hand washing with soap and water.  Use alcohol-based hand gels (containing at least 60% alcohol) when soap and water are not available and hands are not visibly dirty.  Patients with H1N1 influenza should wear a face mask when within 6 feet of others at home. 

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related Conferences:

International Conference on Hepatitis Vaccines, July 25-26, 2016, Australia; 3rd World Congress on Hepatitis and Liver Diseases, Oct 17-19, 2016, UAE; 2nd International Conference on Hepatology, May 12-14, 2016, USA; Annual Conference on Virulent HIV Vaccines, July 28-30, 2016, Thailand; 4th International Conference on HIV/AIDS, STDs, & STIs, Oct 3-5, 2016, USA; International HBV Meeting, Germany; Hep Dart 2015, Hawaii; The Liver Meeting 2015, USA; 2nd Hepatitis Cure & Eradication Meeting 2015, Canada; 4th Canadian Symposium on Hepatitis C Virus, Canada; RSV vaccines for the World, USA; Influenza Vaccines for the World, Portugal; Pathogenesis of Respiratory Viruses, USA; Influenza Vaccines, Bangkok, Thailand; ;  Keystone Symposia Advancing Vaccines in the Genomics Era (T1) Rio de Janeiro, Brazil; Chikungunya Lille, France; Venoms Conference, UK;  Vaccines World China Chengdu, China;  Child Hood Infections Chengdu, China; 22nd Annual Biologics World Taiwan Taipei, Taiwan; 2nd Antivirals Congress Massachusetts, United States; Vaccinology conference Sydney Australia; Vaccines R&D-2015 A New Era in Vaccine Discovery Baltimore, USA; Moldova Vaccine Summit, UK;  1st ATMPH Annual Meeting Symposium Addis Ababa, Ethiopia; The 4th International Veterinary Poultry Congress Exhibition of Iran Tehran, Iran; Third isirv-Antivirals Group Conference: Influenza and Other Respiratory Virus Infections: Advances in Clinical Management, Japan;

Track 5: Influenza Treatment & Therapies

Influenza treatment and therapies are largely supportive and consists of bed rest, increased fluid consumption, cough suppressants, and antipyretics and analgesics.  Patients should be encouraged to stay home if they become ill, to avoid close contact with people who are sick, to wash their hands often, and to avoid touching their eyes, nose, and mouth.  Patients who develop flu like illness (i.  e,  fever with either cough or sore throat) should be strongly encouraged to self-isolate in their home for 7 days after the onset of illness or at least 24 hours after symptoms have resolved,  whichever is longer.  To seek medical care, patients should contact their health care providers to report illness (by telephone or other remote means) before seeking care at a clinic, physician's office, or hospital. 

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related Conferences:

13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, Dalian, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA; RSV vaccines for the World, USA; Influenza Vaccines for the World, Portugal; Pathogenesis of Respiratory Viruses, USA; Influenza Vaccines, Bangkok, Thailand; ; Advancing Vaccines in the Genomics Era (T1) Rio de Janeiro, Brazil; Chikungunya Lille, France; Venoms Conference, UK;  Vaccines World China Chengdu, China;  Child Hood Infections Chengdu, China; 22nd Annual Biologics World Taiwan Taipei, Taiwan. The 4th International Veterinary Poultry Congress Exhibition of Iran Tehran, Iran; Third isirv-Antivirals Group Conference: Influenza and Other Respiratory Virus Infections: Advances in Clinical Management, Japan; Cancer Vaccines: Targeting Cancer Genes for Immunotherapy (X1) British Columbia, Canada; Cancer Immunotherapy: Immunity and Immunosuppression Meet Targeted Therapies (J6) British Columbia, Canada; Immunotherapy and Vaccine Summit Boston, USA; Cancer Vaccines-Advancing Immuno-Oncology London, UK; 3rd Cancer Vaccines and Gene Therapy (CVGT) Meeting The Desmond in Malvern, USA; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; The Foetus New born USA; Vaccine World CIS CEE, Russian Federation. Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Vaccines Conferences  June 16-18, 2016 Rome, Italy; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA;

Track 6: H1N1 Influenza Vaccine

H1N1 influenza is sometimes called "swine flu" because it is usually found in pigs.  You cannot become infected with H1N1 influenza from eating pork products.  H1N1 influenza virus can spread from one person to another through small droplets of saliva that are expelled into the air when an infected person coughs or sneezes.  The virus can also be passed through contact with objects the infected person has touched, such as a door handle or other surfaces.  Becoming infected with influenza is much more dangerous to your health than receiving the vaccine to protect against it.  Most people with H1N1 influenza have recovered, but the virus has caused some deaths.  Like any medicine, this vaccine can cause side effects, but the risk of serious side effects is extremely low. 

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related Conferences:

Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Vaccines Conferences  June 16-18, 2016 Rome, Italy; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, Dubai, UAE; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Melbourne, Australia; Vaccines for Children & Vaccine Preventable Disease Conference South Iselin, NJ; Infectious Diseases in Children A Primary Care and Hospitalist Approach Florida, USA; Colorado Regional Immunization Summit 2015 Grand Junction, CO; 20th Annual Massachusetts Immunization Action (MIAP) Paediatric Immunization Skills Building Conference Marlborough, Massachusetts; GAVI Pledging Conference 2015 Berlin, Germany; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; The Foetus New born USA; Vaccine World CIS CEE, Russian Federation;  Keystone Symposia Advancing Vaccines in the Genomics Era (T1) Rio de Janeiro, Brazil; Chikungunya Lille, France; Venoms Conference, UK;  Vaccines World China Chengdu, China;  Child Hood Infections Chengdu, China; 22nd Annual Biologics World Taiwan Taipei, Taiwan; 2nd Antivirals Congress Massachusetts, United States; Vaccinology conference Sydney Australia; Vaccines R&D-2015 A New Era in Vaccine Discovery Baltimore, USA; Moldova Vaccine Summit, UK;  1st ATMPH Annual Meeting Symposium Addis Ababa, Ethiopia; The 4th International Veterinary Poultry Congress Exhibition of Iran Tehran, Iran; Cancer

Track 7: Recent Advancement in Influenza Vaccine

Influenza can induce serious acute respiratory distress syndrome (ARDS) and non-conventional treatment like extracorporeal membrane oxygenation (ECMO), can be safely instituted in highly specialized centres.  Due to a rapid progression of respiratory failure, transfer of these patients to a referral centre on mechanical ventilation is often infeasible.  Therefore the start of ECMO flu treatment and care at the peripheral hospitals and transportation on ECMO could be a viable option.  The creation of an ECMO team, with experts in the treatment of ARDS, seems a key aspect for the safe management of these patients, including when the most advanced technique are not immediately available. 

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related Conferences:

International Conference on Human Papillomavirus, May 2-3, 2016, USA; Vaccines Conferences  June 16-18, 2016 Rome, Italy; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, Dalian, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, Dalian, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; RSV vaccines for the World, USA; Influenza Vaccines for the World, Portugal; Pathogenesis of Respiratory Viruses, USA; Influenza Vaccines, Bangkok, Thailand; ; Keystone Symposia Advancing Vaccines in the Genomics Era (T1) Rio de Janeiro, Brazil; Chikungunya Lille, France; Venoms Conference, UK;

Track 8: Market Analysis and Manufacturing Technologies

The H1N1 Influenza A (2009) pandemic has affected more than 0.  4 million people in 180 countries across the globe.  The alphabets H and N designate the proteins Hemagglutinin and Neuraminidase present on the surface area of the virus.  The flu first began in Mexico in March 2009, and then affected the U.S., after which it spread across the globe.  The H1N1/09 virus has genetic elements originating from avian, swine, and human sources, making it far more fatal than the 1918 H1N1 (Spanish Flu) outbreak.  The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.  The H1N1 Vaccines market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.  Development policies and plans are discussed as well as manufacturing processes and cost structures are also analysed.  This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. 

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related Conferences:

International Conference on Travel Medicine & Vaccines, May 9-11, 2016, USA; Vaccines Conferences  June 16-18, 2016 Rome, Italy June 16-18, 2016 Rome, Italy ; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Africa Conference on Infectious Diseases, Emergency Risks and Travel Medicine, Nigeria; Infectious Diseases in the Adult Patient: A Primary Care Update, USA; The 15th Conference of the International Society of Travel Medicine, Spain;  Asia Pacific Travel Health Conference , Nepal; The 1st Croatian Congress on Travel, Tropical, Migration Medicine &HIV with international participation, Croatia; Vaccines for Children & Vaccine Preventable Disease Conference South Iselin, NJ; Infectious Diseases in Children A Primary Care and Hospitalist Approach Florida, USA; Colorado Regional Immunization Summit 2015 Grand Junction, CO; 20th Annual Massachusetts Immunization Action (MIAP) Paediatric Immunization Skills Building Conference Marlborough, Massachusetts; GAVI Pledging Conference 2015 Berlin, Germany; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA;

Track 9: Ethical Issues in Pandemic Influenza Virus

Although the timing and severity of the next influenza pandemic is impossible to predict, there is broad agreement that one will occur.  Preparation is vital to mitigating its effects.  A severe influenza pandemic like that which began in 1918 would be unlike other disasters in nature, scale, and duration.  It could cripple normal business operations and disrupt global distribution of essential goods and services.  Public health officials around the world are developing plans for handling an influenza pandemic in response to experts’ warnings that a widespread outbreak of the respiratory virus is inevitable.  A pandemic occurs when a new strain of virus—one to which humans have not developed autoimmunity-becomes highly contagious and spreads across continents.  But knowing when such an outbreak might happen is impossible to predict.  In a severe pandemic flu, veterans’ health association (VHA), like other health care organizations, will face a surge in demand for care to large numbers of very sick people in the context of a highly transmissible disease.  The demand for resources is likely to exceed what is available under ordinary circumstances and restrictions may be necessary to prevent the spread of disease. 

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related Conferences:

12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; Vaccines Conferences  June 16-18, 2016 Rome, Italy; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; 17th International Conference on Vaccines and Immunization, France; 2016 ND State Immunization Conference, USA; 20th Annual Pennsylvania Immunization Conference, Pennsylvania; Idaho; Infectious Diseases in the Adult Patient: A Primary Care Update, USA; Immunize Georgia Conference, USA; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, Dalian, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA; 6th Immunotherapeutic  Immune monitoring Conference California, USA; The Foetus New born USA; Vaccine World CIS CEE, Russian Federation.22nd Annual Biologics World Taiwan Taipei, Taiwan; 2nd Antivirals Congress Massachusetts, United States; Vaccinology conference Sydney Australia; Vaccines R&D-2015 A New Era in Vaccine Discovery Baltimore, USA; Moldova Vaccine Summit, UK;  1st ATMPH Annual Meeting Symposium Addis Ababa, Ethiopia

Track 10: Immunization against viral respiratory disease

Healthy and at risk children are susceptible to the morbidity and mortality associated with viral-induced respiratory diseases, including respiratory syncytial virus (RSV) and influenza. The World Health Organization is attempting to develop and distribute effective vaccines to prevent/reduce key viral respiratory diseases. Effective vaccines are available for some viral respiratory pathogens (e.g: influenza or virus), but not for most mucosal restricted respiratory viral pathogens. Research should continue into safe and effective vaccine for all childhood viral illnesses.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related Conferences:

Vaccines Conferences  June 16-18, 2016 Rome, Italy; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA; Cancer Vaccines-Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Vaccines Conferences  June 16-18, 2016 Rome, Italy; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, Dubai, UAE; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Melbourne, Australia; Vaccines for Children & Vaccine Preventable Disease Conference South Iselin, NJ; Infectious Diseases in Children A Primary Care and Hospitalist Approach Florida, USA; Colorado Regional Immunization Summit 2015 Grand Junction, CO; 20th Annual Massachusetts Immunization Action (MIAP) Paediatric Immunization Skills Building Conference Marlborough, Massachusetts;

Track 11: Respiratory tract infections

Respiratory Tract Infections (RTIs) can spread in several ways. If you have an infection such as a cold, tiny droplets of fluid containing the cold virus are launched into the air whenever you sneeze or cough. If these are breathed in by someone else, they may also become infected. Infections can also be spread through indirect contact. For example, if you have a cold and you touch your nose or eyes before touching an object or surface, the virus may be passed to someone else when they touch that object or surface. The best way to prevent spreading infections is to practise good hygiene, such as regularly washing your hands with soap and warm water.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related Conferences:

Vaccines Conferences  June 16-18, 2016 Rome, Italy; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA; Cancer Vaccines-Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Vaccines Conferences  June 16-18, 2016 Rome, Italy; 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, Dubai, UAE; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Melbourne, Australia; Vaccines for Children & Vaccine Preventable Disease Conference South Iselin, NJ; Infectious Diseases in Children A Primary Care and Hospitalist Approach Florida, USA;

Track: 12 Infections and Infectious Diseases

Infectious diseases also known as contagious diseases, transmissible diseases or communicable diseases are caused by pathogenic microorganisms that infect a host organism and can be spread, directly or indirectly, from one organism to another. Diseases caused by the invasion of a pathogen, including bacteria, viruses, fungi and parasites.  These are typically contagious diseases and include: AIDS/HIV, influenza, common cold, vaccine, sexually transmitted diseases, gastroenteritis, etc.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related conferences:

International Conference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Australia; 12th Euro Global Summit on Cancer Therapy, Sept 26-28, 2016, UK; International Conference and Exhibition on Paediatric Oncology, Aug 4-6, 2016, Canada; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia Vaccines Conferences  June 16-18, 2016 Rome, Italy; Cancer Vaccines: Targeting Cancer Genes for Immunotherapy (X1) British Columbia, Canada; Cancer Immunotherapy: Immunity and Immunosuppression Meet Targeted Therapies (J6) British Columbia, Canada; Immunotherapy and Vaccine Summit Boston, USA; Cancer Vaccines-Advancing Immuno-Oncology London, UK;9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; The Foetus New born USA; Vaccine World CIS CEE, Russian Federation;  Keystone Symposia Advancing Vaccines in the Genomics Era (T1) Rio de Janeiro, Brazil; Chikungunya Lille, France; Venoms Conference, UK;  Vaccines World China Chengdu, China;  Child Hood Infections Chengdu, China; 22nd Annual Biologics World Taiwan Taipei, Taiwan; 2nd Antivirals Congress Massachusetts, United States; Vaccinology conference Sydney Australia; Vaccines R&D-2015 A New Era in Vaccine Discovery Baltimore, USA; Moldova Vaccine Summit, UK; Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy;

Track 13: Respiratory Diseases

Respiratory disease is a medical term that encompasses pathological conditions affecting the organs and tissues that make gas exchange possible in higher organisms, and includes conditions of the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity, and the nerves and muscles of breathing. Respiratory diseases range from mild and self-limiting, such as the common cold, to life-threatening entities like bacterial pneumonia, pulmonary embolism, and lung cancer. A respiratory disease prevents disease, disability, and death through immunological abnormalities and by control of respiratory and related diseases.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related Conferences:

Annual Conference on Virulent HIV Vaccines, July 28-30, 2016, Thailand; 4th International Conference on HIV/AIDS, STDs, & STIs, Oct 3-5, 2016, USA; International HBV Meeting, Germany; Hep Dart 2015, Hawaii; The Liver Meeting 2015, USA; 2nd Hepatitis Cure & Eradication Meeting 2015, Canada; 4th Canadian Symposium on Hepatitis C Virus, Canada; RSV vaccines for the World, USA; Influenza Vaccines for the World, Portugal; Pathogenesis of Respiratory Viruses, USA; Influenza Vaccines, Bangkok, Thailand; ;  Keystone Symposia Advancing Vaccines in the Genomics Era (T1) Rio de Janeiro, Brazil; Chikungunya Lille, France; Venoms Conference, UK;  Vaccines World China Chengdu, China;  Child Hood Infections Chengdu, China; 22nd Annual Biologics World Taiwan Taipei, Taiwan; 2nd Antivirals Congress Massachusetts, United States; Vaccinology conference Sydney Australia; Vaccines R&D-2015 A New Era in Vaccine Discovery Baltimore, USA; Moldova Vaccine Summit, UK;  1st ATMPH Annual Meeting Symposium Addis Ababa, Ethiopia; The 4th International Veterinary Poultry Congress Exhibition of Iran Tehran, Iran; Third isirv-Antivirals Group Conference: Influenza and Other Respiratory Virus Infections: Advances in Clinical Management, Japan;

Track 14: Vaccines and Therapeutics

Vaccines also may contain very small amounts of the culture material used to grow the virus or bacteria used in the vaccine, such as chicken egg protein. Scientists have long figured it should be possible to rev up the immune system on command, to give the body's own natural defences an extra surge of power to attack tumour’s and fight diseases. But decades of working on the challenge have seen many promising clinical trials of potential "immune modulators," "immune stimulators" and "therapeutic vaccines" end in disappointment.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Related Conferences:

12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, UAE; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Africa Conference on Infectious Diseases, Emergency Risks and Travel Medicine, Nigeria; Infectious Diseases in the Adult Patient: A Primary Care Update, USA; The 15th Conference of the International Society of Travel Medicine, Spain;  Asia Pacific Travel Health Conference , Nepal; The 1st Croatian Congress on Travel, Tropical, Migration Medicine &HIV with international participation, Croatia; Vaccines for Children & Vaccine Preventable Disease Conference South Iselin, NJ; Infectious Diseases in Children A Primary Care and Hospitalist Approach Florida, USA; Colorado Regional Immunization Summit 2015 Grand Junction, CO; 20th Annual Massachusetts Immunization Action (MIAP) Paediatric Immunization Skills Building Conference Marlborough, Massachusetts; GAVI Pledging Conference 2015 Berlin, Germany; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa

Track 15: Entrepreneurs Investment Meet

The Indian economy is among the fastest growing economies in the world.  The country forayed into manufacturing vaccines starting with a few public-sector manufacturers in the late 1960s but has emerged as the major supplier of basic Expanded Programme on Immunization vaccines to the United Nations.  In addition to the need for vaccines and ancillary products, there was also a clear need for funding to support the costs of safely deploying vaccines to countries,  and for safely distributing and administering them within the systems of recipient countries once they arrived.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. Related Conferences:

13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Africa Conference on Infectious Diseases, Emergency Risks and Travel Medicine, Nigeria; Infectious Diseases in the Adult Patient: A Primary Care Update, USA; The 15th Conference of the International Society of Travel Medicine, Spain;  Asia Pacific Travel Health Conference , Nepal; The 1st Croatian Congress on Travel, Tropical, Migration Medicine &HIV with international participation, Croatia; World Vaccine Congress, USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; The Foetus New born USA; Vaccine World CIS CEE, Russian Federation;  Keystone Symposia Advancing Vaccines in the Genomics Era (T1) Rio de Janeiro, Brazil; Chikungunya Lille, France; Venoms Conference, UK 13th­ Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016), December 01-02, 2016 at Atlanta, USA; 12th Global Vaccines & Vaccination Summit and Expo, Oct 20-22, 2016, Dubai, UAE; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Melbourne, Australia; Immunotherapy and Vaccine Summit Boston, USA; Cancer Vaccines-Advancing Immuno-Oncology London, UK;9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA; 6th Immunotherapeutics Immunomonitoring Conference California, USA; The Foetus New born USA; Vaccine World CIS CEE, Russian Federation;  Keystone Symposia Advancing Vaccines in the Genomics Era (T1) Rio de Janeiro, Brazil; Chikungunya Lille, France; Venoms Conference, UK;  Vaccines World China Chengdu, China;  Child Hood Infections Chengdu, China; 22nd Annual Biologics World Taiwan Taipei, Taiwan.

 





Tracks and Sub-Tracks

TRACKS AND SUB TRACKS

Track 1: Status of vaccines research and methodology

Track 1-1Survey of Vaccine-Preventable Diseases

Track 1-2Vaccine Efficacy and Safety

Track 1-3Vaccine Safety Surveillance and Evaluation

Track 1-4Cost-Effectiveness Analyses and Evaluation

Track 1-5Vaccine Implementation Options

Track 1-6Warnings and Precautions

Track 1-7Preparation of the Vaccine Strain

Track 1-8Vaccine Bulk Manufacture

Track 2: Influenza Virus- Immunology and Genetic Features

Track 2-1The Biology of H1N1- Genome Structure

            Track 2-2Influenza Virus and Strains

            Track 2-3Influenza Antigenic Changes- A(H1N1) Immune Escape Mutants

            Track 2-4Immuno Response

            Track 2-5Antiviral Resistance

            Track 2-6Evolution and Genetic Diversity

Track 3: Transmission and Diagnosis of H1N1 influenza Virus

            Track 3-1Assessing Influenza Virus Deposition and Survival in the Environment

            Track 3-2Genetic Variations

            Track 3-3Outbreak Investigations

            Track 3-4Prospective Intervention Studies in the Setting of Natural Infection

            Track 3-5Molecular Diagnostics

            Track 3-6Virus Isolation and Typing using Haemagglutination Inhibition or Immunofluorescence

            Track 3-7Rapid Tests or Immunofluorescence

            Track 3-8Reverse Transcription PCR

Track 4: Influenza Epidemiology and Disease Management

Track 4-1Rapid Containment of Pandemic Influenza : Strategy and Protocol

Track 4-2Global Outbreak and Alert Response Network : A(H1N1) Initial Alert and Response

Track 4-3Country Operation Support and logistics Coordination : Antiviral Stockpile Deployment

Track 4-4EMS (Event Management System)

Track 4-5Monitoring and Tracking Global and Regional Progression,  Transmission,  and Impact of the Pandemic

Track 4-6Generating and Sharing Authoritative Information to Support Country Interventions and Mitigation Strategies

Track 5: Influenza Treatment & Therapies

            Track 5-1Antiviral Therapy

            Track 5-2Considerations

            Track5-3Complications

            Track5-4Comorbidity-Problems

            Track5-5Others

Track 6: H1N1 Influenza Vaccine

Track 6-1Indication and Usage – Dosage and Administration

Track 6-2Dosage Forms,  Strengths and Contraindications

Track 6-3Adverse Reactions and Drug Interactions

Track 6-4Use in Specific Populations- Description

Track 6-5Clinical Pharmacology and Nonclinical Toxicology

Track 6-6Clinical Studies

Track 7: Recent Advancements in Influenza Vaccine

Track 7-1New Protective Vaccines

            Track 7-2Vaccines Effective against Newly Emerging Influenza Viruses

            Track 7-3Adjuvant Development,  from Early Discovery to Clinical Evaluation

            Track 7-4Safety and Efficacy in Special Populations

Track 8: Market Analysis and Manufacturing Technologies

Track 8-1Surveillance

Track 8-2Verification of Vaccine Strain

Track 8-3Preparation the of Reagents to Test the Vaccine (with reference reagents)

Track 8-4Optimization of Virus Growth Conditions

Track 8-5Vaccine Bulk Manufacture

Track 8-6Quality Control

Track 8-7Vaccine Filling and Release

Track 8-8Recent Techniques and Innovation

Track 9:  Ethical Issues in Pandemic Influenza Virus

Track 9-1Equitable Access to Therapeutic and Prophylactic Measures

Track 9-2Isolation, Quarantine,  Border Control and Social-Distancing Measure

Track 9-3The Role and Obligations of Health-Care Workers during an Outbreak of Pandemic Influenza

Track 9-4Pandemic Influenza Planning and Response – Transnational Issues for Government

Track 10: Immunization against viral respiratory disease

             Track 10-1 viral-induced respiratory diseases

             Track 10-2 viral respiratory infections 

             Track 10-3 viral respiratory pathogens

             Track 10-4 Various RSV vaccine formulations

             Track 10-5 Immunological disorders

Track 11: Respiratory tract infections

             Track 11-1 Nasopharyngeal cold

             Track 11-2 Lung Diseases

             Track 11-3 Pharyngitis

             Track 11-4 Epiglottis

             Track 11-5 Otitis

Track 12:  Infections and Infectious Diseases

             Track 12-1 Cervical Dysplasia

             Track 12-2 Allergy

             Track 12-3 HIV/ AIDS

             Track 12-4 Aspergillosis

             Track 12-5 Gynaecological Infections

Track 13: Respiratory Diseases

Track 13-1 Bronchial Asthma

Track 13-2 Chronic Obstructive pulmonary Disease

Track 13-3Pnemonia

Track 13-4 Chronic Bronchitis

Track 13-5 Emphysema

Track 14: Vaccines and Therapeutics

Track 14-1 Anti-microbial Resistance

Track 14-2 Emerging Infectious Diseases

Track 14-3 Antimicrobials and Latest Innovations

Track 14-4 Immunological Resistance

Track 14-5 immune modulators

Track 15: Entrepreneurs Investment Meet

Track 15-1Flu Vaccines Expect More Modern

Track 15-2Effective Versions-About to hit market

Track 15-3Accelerating vaccine development

Track 15-4Regulatory reform

Track 15-5Improving pandemic vaccine deployment

Track 15-6Collaborations

Track 15-7Business Development

Track 15-8Investment and Development

 





Market Analysis

The 13th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics to be held at Atlanta, USA during December 01-02, 2016 hosted by Conference Series LLC through the theme "Research and Methodology Implemented on Influenza Vaccines & Respiratory diseases", conference will explore the advances in Vaccines and vaccination. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium cognizance on vaccines and vaccination, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world. Conference Series LLC Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members and Organizes 300+ Conferences every year across Asia Pacific, USA &Europe with support from 1000 more scientific societies.

Vaccination is a key to eradicate the diseases. It is a subject for the professionals who looks beyond the clinical prospects. IRDI Vaccines 2016 amasses all the extroverts under one roof of current advances.

For more details please visit-http://h1n1-influenza.conferenceseries.com/

Vaccinology is a major field in eradication of diseases. Traditional approaches to vaccine design were to emasculate or inactivate the human pathogen or a cognate animal homologue, Vaccinology is the science of vaccine development and how the immune system responds to vaccines, but additionally includes perpetual evaluation of immunization programs and vaccine safety and efficacy, as well as surveillance of the epidemiology of vaccine-preventable diseases. This chapter provides a brief overview of some of the main concepts of immunology and Vaccinology as they relate to immunization.

Why Atlanta? 

In 2014-15 there are 9 vaccines and related conferences are held in USA.             

When you think about Atlanta, the first thing that probably comes to mind is a flashback to those Bravo commercials you've seen with The Real Housewives. But forget Nene and Kandi -- Atlanta is much more than fake-brawling and M.C. Mansion suburbs. This city is one of the most amazing cities in America, and these are the reasons why: Every city has big attractions, but Atlanta's are pretty hard to beat. The city has one of the world's largest aquariums, with over 60 exhibits and an astounding 10 million gallons of water. Something else unique to the aquarium? Swimming with whale sharks. Don't worry, it's safe. Atlanta is poised to be the Florence of the Digital Age. There’s a rumbling of chatter and growing excitement about Atlanta and its future. You hear it at every marketing event. Every digital conference. You hear it every time a local politician speaks. You see it on billboards and in blog posts written by community leaders. And I suppose everybody wants their city to be the best. To believe their city is the best. But in Atlanta, that feeling doesn’t come from a place of default hometown pride. It doesn’t come from a place of hubris or lack of worldliness.

Conference Highlights: 

·        Status of vaccines research and methodology

·        Influenza Virus- Immunology and Genetic Features

·        Transmission and Diagnosis of H1N1 influenza Virus

·        Influenza Epidemiology and Disease Management

·        Influenza Treatment & Therapies

·        H1N1 Influenza Vaccine

·        Recent Advancement in Influenza Vaccine

·        Market Analysis and Manufacturing Technologies

·        Ethical Issues in Pandemic Influenza Virus

·        Immunization against viral respiratory disease

·        Respiratory tract infections

·        Infections and Infectious Diseases

·        Respiratory Diseases

·        Vaccines and Therapeutics

·        Entrepreneurs Investment Meet

Why to attend???

IRDI Vaccines 2016 could be an event that brings along a novel and International mixture of giant and medium Vaccinology innovation and incipient trends in vaccines and vaccination, leading universities and Vaccinology, vaccination research analysis establishments creating the conference an ideal platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Vaccinology research are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

h1n1influenza@insightconferences.com

Major Vaccines Associations in &around Atlanta.

·     Vaccine research Association

·     National Vaccine Information Centre (NVIC)

·     Think twice Global Vaccine Institute

·     Vaccination Liberation

·     American Medical Association

Major Vaccines Associations Globally

·     The International Society for Interferon and Cytokine Research

·     The International Society of Neuro immunology

·     The International Union of Immunological Societies

·     The Society for Mucosal Immunology

·     The Society for Leukocyte Biology

·     Transplantation Society

·     British Society for Immunology

·     Cell Death Society

·     European Federation of Immunological Societies

·     European Society of Gene Therapy

·     Federation of African Immunological Societies

·     Federation of American Societies for Experimental Biology

·     Federation of Clinical Immunology Societies

·     Immune Deficiency Foundation

·     Infectious Diseases Society of America

Target Audience:

IRDI Vaccines 2016 Targets, CEO’s, Directors, Scientists, Professors, Students of all Biotech & Pharma companies, Universities and colleges globally

Vaccines sales in global leader companies 2012(1st quarter):

·     Pfizer 2.2 B $

·     Sanofi 1.7 B $

·     Merck & Co 1.8 B $

·     GSK 2.5 B $

·     Novartis 0.44 B $

·     EBS 0.88 B $

Companies Associated with Vaccines

·     Cared

·     Atara

·     Bio therapeutics

·     Benitec Limited

·     InterMune

·     Biotron Limited

·     BioDiem

·     Antisense Therapeutics Limited      

·     GlaxoSmithKline USA Pty Ltd

·     Bionomics

·     USA Pharmaceutical Industries (API)  

·     Bio Pharma Limited

 

Market Analysis of Vaccines

Tripled in value from USD 5B in 2000 to almost USD 24 B in 2013, Global market projected to rise to USD 100 B by 2025. More than 120 new products in the development pipeline. 60 are of importance for developing countries. UNICEF had a market of 1,03 B$ in 2011, PAHO had 400 million dollars in 2011 and total UN market of 340 million dollars in 2002, 1,430 billion dollars in 2011.

Overall Statistics

 





Past Conference Report

Vaccines Asia Pacific-2015

Sensing the raising importance of Vaccines, Conference Series LLC hosted the 5th Asia pacific Global Summit and Expo on Vaccines & Vaccination” (Vaccines Asiapacific-2015), scheduled from July 27-29, 2015 in Brisbane, Australia with a theme “Vaccine Research: From Bench to Bedside”.  Benevolent response and active participation was received from the Editorial Board Members of Our Journals as well as from the Vaccines project managers, Vaccinologists, Immunologists, Vaccine researchers, scientists, doctors, students and leaders from the fields of Vaccines and Vaccination, Immunology, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

  • Technologies for the Design, Discovery, formulation and administration of vaccines.
  • Developing Next-Gen Conjugate Vaccines.
  • New trends in carbohydrate-based vaccines.
  • Vaccines for Pregnant Women.
  • Recent advances in animal vaccination
  • Adjuvants for human vaccines—current status, problems and future prospects.
  • Current developments in bacterial conjugate vaccines potency.
  • Recent trends in attenuated vaccines.
  • Advancements in vaccine development
  • Vaccination and quality of life
  • Protein subunits- vaccination.
  • Toxoid vaccines and its importance
  • Geriatric Immunization
  • Vaccines under research and development, major diseases
  • Innovative development of vaccines

The conference was embarked with an opening ceremony followed by workshop and a series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

Dr. Nikolai Petrovsky, Flinders University, Australia

Dr. Roy Hall, The University of Queensland, Australia

Dr. Jan Fohlman, Växjö and Uppsala University, Sweden

Dr. Istvan Toth, the University of Queensland, Australia

Young Researchers:

Towards the development of oral vaccine delivery systems for lipid core peptide-based vaccines using novel multi-layer engineered Nano liposomes against Group A streptococcus

Nirmal Marasini, The University of Queensland, Australia

Title: A Protective Immune Response Using Asymmetric Multi-Epitope Self-Adjuvanting lipopeptide Vaccine Model

Sharareh Eskandari, the University of Queensland, Australia

Title: Binding and immune modulation properties of mannosylated lipo-peptide vaccines

Bita Sedaghat, The University of Queensland, Australia

Title: Liposomes as a Delivery Platform of Vaccines Against Group A Streptoccocus

Khairunnisa Abdul Ghaffar, University of Queensland, Australia

            Conference Series LLC offers its heartfelt appreciation to Societies and Organizations, Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference Series LLC in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Vaccines Asiapacific-2015, Conference Series LLC is delighted to announce the next event.  Mark your calendars for the upcoming extravaganza," 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination" to be held during October 17-19, 2016 Kuala Lumpur, Malaysia.

Keynote Forum

Tracks

Posters Accepted Abstracts

 For More details: http://vaccines.global-summit.com/asia-pacific/2015/

Vaccines 2014 report

The 4th International Conference on Vaccines & Vaccination, hosted by the Conference Series LLC. It was held in September 24-26, 2014 Valencia, Spain. Generous response and active participation was received from the Editorial Board Members of Conference Series LLC Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2014 from Conference Series LLC. Also, the conference was carried out through various sessions, in which the discussions were held on the following scientific tracks:

Overview

http://www.conferenceseries.com/immunology-conferences.php

• Vaccines and the Basic Immune System

• New Approaches for B and T Cells

• Cellular and Molecular-Based Vaccines

• Vaccines against Infectious Diseases

• Manufacturing, Production and Development of Vaccines

• Regulatory and Ethical Issues of Vaccines and Public Acceptance

• Current Issues on Clinical Evaluation and Field Trials of Vaccines

• Modern Technologies in Vaccine Discovery and Development

• Age-Specific Immune Response to Vaccination

• Novel Delivery technologies in Vaccines and many more...

The response to 4th International Conference on Vaccines & Vaccination was huge and was attended by about 550 attendees representing 55 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honourable Guests and members of the keynote forum. The list included

Jeffrey B Ulmer, Novartis Vaccines USA

Ray Spier, Former President, International Society for Vaccines, UK

Michael G Hanna, CEO, Vaccinogen, Inc., USA and many more...

All the above mentioned Honourable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2014.

All accepted abstracts have been indexed in Conference Series LLC -Journal of Vaccines & Vaccination as a special issue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.

Conference Proceedings

Keynote speakers

Scientific Tracks

Posters

Accepted Abstracts

Sponsors and exhibitors

Sanofi Pasteur SA

U.S. Headquarters, Discovery Drive, Swift water, PA 18370

Vaccinogen Inc.,

5300 West view Dr # 406, Frederick, MD 21703, United States

Cellular Technology Limited (CTL)

North & South America

CTL Headquarters, 20521 Chagrin Blvd., Shaker Heights, OH 44122-5350 USA,

Gen Phar

600 Seacoast Pkwy # 100,

Mt Pleasant, SC 29464, United States

Vaccines-2013 Report

Conference Series LLC, the global leader in organizing annual “International conferences and Exhibitions on Vaccines and Vaccinations” The Annual Vaccines Conferences provides high-quality, current reports of scientific progress and best practices featured in both invited presentations and submitted oral abstracts and posters. The Global Vaccines Conferences and Expos organized by Conference Series LLC, bring together the diverse disciplines involved in the research and development of vaccines and associated technologies for disease control through immunization. By drawing upon an global audience of CEOs, CSOs, scientists and researchers, healthcare professionals and trainees, veterinarians, vaccine manufacturers, and public health officials, the conference is designed to encourage the exchange of ideas across a broad range of disciplines.

 Highlights of Annual Global Vaccines Conferences-Conference Series LLC

 • Keynote forum

• Exhibitions

• Company Presentations

• Speaker Forum

• Workshops and Symposia’s

• B2B Meetings

• One to One meeting

• Special Session for Students

• Scientific writing

• Journal review

• Grant writing

• Strategies for building a scientific career

• Scientific careers outside of research

• Company Promotions

• Young Research Forum

• Best Poster Awards

• Certification by the “International Organizing committee” and many more... 

Vaccines-2012 Report

The 2nd International Conference on Vaccines & Vaccination, hosted by the Conference Series LLC. It was held in August 20-22, 2012 in Hilton Chicago/North book, USA. Generous response and active participation was received from the Editorial Board Members of Conference Series LLC Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2012 from Conference Series LLC. Vaccines 2012 hosted 300+ attendees representing 55 countries from different corners of the world. The conference was carried out through various sessions, in which the discussions were held on the following

 Scientific tracks:

• Vaccines and the Basic Immune System

• New Approaches for B and T Cells

• Cellular and Molecular-Based Vaccines

• Vaccines against Infectious Diseases

• Manufacturing, Production and Development of Vaccines

• Regulatory and Ethical Issues of Vaccines and Public Acceptance

• Current Issues on Clinical Evaluation and Field Trials of Vaccines

• Modern Technologies in Vaccine Discovery and Development

• Age-Specific Immune Response to Vaccination and many more...

 Conference Proceedings

Keynote speakers

Scientific Tracks

Posters

Accepted Abstracts

The response to 2nd International Conference on Vaccines & Vaccination was huge and was attended by about 300 attendee’s representing 25 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honourable Guests and members of the keynote forum. The list included

 De-Chu Christopher Vaxin Inc., USA

John Dong GenPhar, USA

Donald E. Greydanus Western Michigan University School of Medicine, USA

Eli Young OpSaniTx, USA

Takashi Kei Kishimoto Selecta Biosciences, USA

Daniel H Zimmerman CEL-SCI Corporation, USA

Gerardo Kaplan FDA, USA

Kei Amemiya U.S. Army Medical Research Institute of Infectious Diseases, USA

Haval Shirwan  University of Louisville, USA and many more.

All the above mentioned Honourable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2012.All accepted abstracts have been indexed in Conference Series LLC- Journal of Vaccines & Vaccination as a special issue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.

 Vaccines-2011 Conference Report

The International Conference and Exhibition on Vaccines & Vaccination (Vaccines-2011) was held on November

22-24, 2011 in Philadelphia Airport Marriott Hotel, USA. This successful conference organized by Conference Series LLC brought together Medical Specialists, Researchers and Vaccine Developers who were delighted with the many speeches, presentations, and discussions, which demonstrated the determination to innovate and improve knowledge on Vaccines.Vaccines-2011, helped to open new ideas, advanced technologies, innovative approaches towards Vaccines. Several speakers from almost 30 countries have participated in this conference which was carried out through several sessions with the theme “Current Strategies in Vaccination”.

Conference highlighted the following topics:

• Vaccines and the basic immune system

• New approaches for B and T cells

• Cellular and molecular-based vaccines

• Vaccines against infectious diseases

• Therapeutic vaccine manufacturing, production and development

• Logical and ethical issues and vaccines

• Experimental and clinical evaluation of therapeutic vaccines

• Basic Vaccinology and modern vaccine discovery technologies and many more...

The Luxurious accommodation during the conference also created a relaxed and informal atmosphere with

Aright setting for highly interactive sessions where the speakers shared the knowledge on current issues and

Strategies of Vaccines and Vaccination.

We take an immense pleasure in thanking our Keynote Speakers:

Gary Alan Flory Virginia Department of Environmental Quality, USA

Gregory J. Tobin Biological Mimetics, Inc. (BMI), USA

Kei Amemiya US Army Medical Research Institute, USA

Edmund J. Gosselin Albany Medical College, USA

Mansour Mohamadzadeh University of Florida, USA and many more...

Vaccines 2011 hosted 200+ attendees representing 30 countries from different corners of the world.

 Conference Proceedings

Keynote speakers

Scientific Tracks

Posters

Accepted Abstracts

We are grateful to all speakers, scientific societies, governmental and non-governmental institutions, Professors, scientists, representatives of patient groups from throughout the world for their commitment and the support. We would like to thank our organizing committee members for providing advice on the agenda, and in supporting the conference. We are grateful to NIH, GSK, Sanofi Pasture, and other sponsors for their invaluable support for the success of the event. Journal of Vaccines & Vaccination and Journal of Clinical & Cellular Immunology have published all papers presented at this meeting as a special issue. With the over whelming response and suggestions and feedbacks from our previous attendees. Conference Series LLC is organizing its Global Vaccines conferences in major countries across the globe: We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Vaccines-2012.


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date December 01-02, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2
Poster Opportunity Available

Media Partners

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
irdivaccines@conferenceseries.com
Sponsors / Exhibiting / Advertising.
General Queries.

View Proceedings of Previous Conferences

Vaccines Asia Pacific 2016
Dubai Vaccines 2015
Euro Vaccines 2015
American Vaccines 2015
Authorization Policy

By registering for the conference you grant permission to Conferenceseries Ltd to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.